UnitedHealthcare
Velcade (
bortezomib
)
Drugs for Cancer : Drugs for Cancer
Prior Authorization: Mantle Cell Lymphoma:
Documented Diagnosis: Yes
Duration: 12 Month(s)
Mantle Cell Lymphoma:
Duration: 12 Month(s)
Documented Diagnosis: Yes
Medical Test Required: No
Reauthorization Required: No
Duration of Reauthorization: N/A
<< Return
|
Back to top